Stock AMNI AMNIOTICS AB
Add to a list
To use this feature you must be a member
Log inSign up

Financials Amniotics AB

Equities

AMNI

SE0015961016

Biotechnology & Medical Research

Market Closed - Nasdaq Stockholm
Other stock markets
 09:25:49 2024-04-26 am EDT 		5-day change 1st Jan Change
0.0038 SEK 0.00% Intraday chart for Amniotics AB 0.00% -57.78%
Mar. 22 Magle Chemoswed Holding AB (OM:MAGLE) made a tender to acquire 99.96% stake in Amniotics AB (OM:AMNI) from LSCS Invest AB, Deflexum AB, Marcus Larsson and other for SEK 10.9 million. CI
Feb. 22 Amniotics AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025
Capitalization 1 174.5 19.04 10.39 10.39 -
Enterprise Value (EV) 1 130.5 19.04 24.39 2.486 10.39
P/E ratio -3.25 x - - - -
Yield - - - - -
Capitalization / Revenue - - - - -
EV / Revenue - - - - -
EV / EBITDA -3.38 x -0.42 x -0.91 x -0.44 x -0.44 x
EV / FCF -11,160,105 x - - - -
FCF Yield -0% - - - -
Price to Book - - - - -
Nbr of stocks (in thousands) 16,066 16,066 2,733,052 2,733,052 -
Reference price 2 10.86 1.185 0.003800 0.003800 0.003800
Announcement Date 2/17/22 1/19/23 2/22/24 - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025
Net sales 0.0376 - - - - -
EBITDA 1 - -51.62 -44.9 -26.77 -23.7 -23.6
EBIT 1 - -53.62 -46.69 -29.07 -23.7 -23.6
Operating Margin - - - - - -
Earnings before Tax (EBT) 1 - -53.62 -48.05 -30.87 -23.7 -23.6
Net income 1 -31 -53.62 -48.05 -30.87 -23.7 -23.6
Net margin -82,329.93% - - - - -
EPS - -3.340 - - - -
Free Cash Flow - -15.63 - - - -
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 3/18/21 2/17/22 1/19/23 2/22/24 - -
1SEK in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025
Net Debt - - - - - -
Net Cash position - 44 - - 7.9 -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow - -15.6 - - - -
ROE (net income / shareholders' equity) - - - - - -
ROA (Net income/ Total Assets) - - - - - -
Assets 1 - - - - - -
Book Value Per Share - - - - - -
Cash Flow per Share - - - - - -
Capex - - - - - -
Capex / Sales - - - - - -
Announcement Date 3/18/21 2/17/22 1/19/23 2/22/24 - -
1SEK in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
AMNIOTICS AB Stock Amniotics AB
-57.78% 947K
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.51% 42.75B
LONZA GROUP AG Stock Lonza Group AG
+49.22% 41.61B
MODERNA, INC. Stock Moderna, Inc.
+8.57% 41.34B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.59B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.92% 25.49B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-25.13% 18.12B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.17% 12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.12% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.35% 11B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. AMNI Stock
  4. Financials Amniotics AB